{"name":"C.T. Development America, Inc.","slug":"c-t-development-america-inc","ticker":"","exchange":"","domain":"","description":"C.T. Development America, Inc. is a biopharmaceutical company focused on the development of innovative treatments for various diseases. The company's pipeline includes three drug candidates, with KIACTA (eprodisate disodium) in Phase 3 and two others in Phase 2.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KIACTA (eprodisate disodium)","genericName":"KIACTA (eprodisate disodium)","slug":"kiacta-eprodisate-disodium","indication":"Transthyretin (TTR) amyloidosis","status":"phase_3"}]}],"pipeline":[{"name":"KIACTA (eprodisate disodium)","genericName":"KIACTA (eprodisate disodium)","slug":"kiacta-eprodisate-disodium","phase":"phase_3","mechanism":"Eprodisate disodium inhibits glycosaminoglycan (GAG) synthesis and accumulation by blocking the formation of pathogenic protein-GAG complexes in amyloid-related diseases.","indications":["Transthyretin (TTR) amyloidosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMS1vNFpjOS1PVV8yRDVGNzkyUFBsd3dUcWQySExmVENHeTJLWV93VjNxeFpncnVXMVp2QWtSWk5EdzBVeDBZcERxem5WYjRoYjRsSE80bjd1S2k1SkRtdGpnall4dHEyTXQyUTl2Z182UTN4bENacW1vV0hLVjNmVFgtRnlncU5tazRDZExZMFNEeWxSd1BscTFNUG9iempadEZ5Sk54Tzd3NUIy?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Nuclear Medicine Market Size & Global Growth Report [2034] - Fortune Business Insights","headline":"Nuclear Medicine Market Size & Global Growth Report [2034]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPejdMLVdlMFNaVkVjOXBzMG5YQVhXOHVrN1dkZVdRV3VjRGxzeXBscUpVLTI5bWlQU3FPcU0tSUdnNUxHM01qNmppeE04Q3dya0RyY05QWHNjZXpTRllQUzc0ejR2TlQ2Rk5aZVh3M1k2YU00TGVraGlMRTVhWEtWa9IBlAFBVV95cUxQNnZFMHpBbGhzSVpyQmFYSnFOQldWbUtNZjdhVUxwclY3SURqTnJzVDNkZHVhNFFTSEhGRl8ta3ZiT3NqeFhZMFVmclpvS0FycFhiSzhPQlowRGI1RmUtdW51aGNDaUZIYmQxTUI1eGQzSF9ESDRUd0ZQaFFkSENRMzhNb2JKRTVfQkE3MEprVmtkVVUt?oc=5","date":"2026-01-14","type":"pipeline","source":"Chosunbiz","summary":"Celltrion pivots to new drugs and will start US CMO operations next month - CHOSUNBIZ - Chosunbiz","headline":"Celltrion pivots to new drugs and will start US CMO operations next month - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQaVR5RFZ2ZW9wYTRObWdDdkRoazZwV3FGak1rSjRHbjBoSmxoNzlYWkdzaWRzbGlpR3JISWFYRjQzNEpRekQ1dUR4bmdBWTF6clBXemp4cjFocFczZ1FYa3BrbGpwZHA4Ukh0bDdpbV9VcDdpT3RndkxCRVNYMkJwakh2WmhsaC1RTG1sekdLejZrSFJJb3lROGJFYWN3RFV0R0tNeHlhVQ?oc=5","date":"2025-12-23","type":"pipeline","source":"CT Insider","summary":"Boehringer Ingelheim to invest $10B in research and development, pledges to cut medicine costs - CT Insider","headline":"Boehringer Ingelheim to invest $10B in research and development, pledges to cut medicine costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxQQXJaSFdNcDQxc0x5dmk1ZTExRlE5dGN4SjFjMGlvNlpxOXlvdmRfOURJQ1l5UC1aRC1WNTZLcmtkN1lQQkRLRVc4OF9STk9saEEzNkMzWHVxTEZYOVJKbzA3a081NEFrZjA5VlJqbm1GWXdXTFR2eXhEQVpFTDhGQVp3RVBNT0VLSUNxeS1FN0N5aTFkVnZvQ1N6U1hxTnRoWGZqWUJUWFI1ZkJ1aWd0RDEyeGVhUW1KVG84RXpPd3Bzem1OTDdJVjd4WFRKZEhOTEZXYmpaZE55TTJWWWpwY3pqQm5QTTdrelhXWUNaOGhlWHgycXJPT3M0WHY1NDRWWFY3ZlAyYVA1VWZ5UmVUdFRwdnlmMHE2a0lYRm5TTVJ3WUhfSVRQR0FRM3FJTE0?oc=5","date":"2025-12-19","type":"pipeline","source":"PR Newswire","summary":"Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint - PR Newswire","headline":"Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American pati","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-22","type":"pipeline","source":"Business Wire","summary":"Palleon Pharmaceuticals to Present on Development of HLX79/E-602 in Autoimmune Disease at the American College of Rheumatology Convergence Annual Meeting and the American Society of Nephrology Kidney ","headline":"Palleon Pharmaceuticals to Present on Development of HLX79/E-602 in Autoimmune Disease at the American College of Rheuma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPRnhSdzVnZkdDSk1MWDhsSTZiNGU4d0EycVdDQThwMm8zVDNKMnhXOFVFSDZwOTZDYzh3c0U3NDUzaE5objZZYVdORlF2eEpTOHZraE9zaFlOZEZfRFRua0IyLThNdklOVzlBYmd4S3dMdUNNRWVGZ2hQR0ZJaWNiVlVkNW42a3UtZTZOV1RBOVE?oc=5","date":"2025-10-17","type":"pipeline","source":"CBIA","summary":"‘Getting Stronger:’ Five Days on the Manufacturing Road - CBIA","headline":"‘Getting Stronger:’ Five Days on the Manufacturing Road","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxNS3FOWFp4aUVuVzNfbVpKaGtVLWRNamRVUkNCZjdmT2RlY1NaaUdOMWx3N1JJbnBFY2U0bDhuMDh2cUEyUFNJaUZIUmI2OGVPaE5nQUhwckdLMnI2MlVjVHNFcVZ2RVh0RndsUVdxMzNpTng5eUU4N2Rucl9VVVUwM1dmLUowaFhqRzI1VndScDZnRklETmdWTE9DQ013UG4xMXRXMHhQekZKcUJ3V3VCR0NQWXYzQmZxZS12bzVKeEZYby1sdFphR0dra3h1Q1owQVk4Mkt2R0ltLUJudmhkakR4RUd0cnZBTUExX1Nhd0kxR3JRT0FJN3lRbWlSUWtSd0FqcnhCV2dMTWI4clMtcFREUTlKamNGakxvcmIzRXBpSFhicWdHRDM5R3dfTE15ZlVMT09wTkNhc3FDR2lLdXJqM1J0UQ?oc=5","date":"2025-09-09","type":"deal","source":"BioSpace","summary":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia - BioSpace","headline":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNVEZnRmpxSlNZR2FtYmVxUXhXN1lrZ04wMUp1SjlVbFpyZ2lVZDE4cDM3dnY3Z2hoSkpGVEJSaV9UUzNYeHZXLTJLQV9nUjdNUDYtekFVN2RqNGVmbDNSRHZ5RjhXRmhWbkc3R3RhVTY5Y0JkVmV4d1ltSDZPcGhzVHlQVm9kNG5lMThxbVlOY3c2LUdoLWdXMW1lQUl6a29CbEI1VE9fOGh0Rjl1NWs3aQ?oc=5","date":"2025-09-05","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation - Pharmaceutical Commerce","headline":"Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPVnpoMnd1V001YVhORU9scXFmMklqbXJ3Mm9KTnRoWW1HYi04bzJpdzF1YzdnX2ZnbzhmT0NsaWZIUWVUd29MVFVvazlod2VYZ1ZUR05Vcm5IQ2RZQ19yQ2EydmxWU2M3WVJaR290QlRQR0hjVU9GQ05ic2lsOExsaHZSRQ?oc=5","date":"2025-04-24","type":"pipeline","source":"Manufacturing Chemist","summary":"Roche to put $50bn into US manufacturing and R&D footprint - Manufacturing Chemist","headline":"Roche to put $50bn into US manufacturing and R&D footprint","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPWnIyUnlTN2tFMlMxaW12R2RSSVFLLTNtbU94Q0l4UkFMRzlNQ3hXMGI4WlFicllkSVJ5UTMwMnpUSFk3X3VJY3N6WnZzVDhjVE9FREo3TE9hY0NqVkNpeU41eHlGeGc5REJwWHpmMWU4WC1STmN2ZVJkbWdrS1QtWWc0amRSVTFveGdtMWh2clVBSEx4?oc=5","date":"2025-03-21","type":"pipeline","source":"America First Policy Institute","summary":"Put Americans First by Ending Global Freeloading | Issue Brief | Healthcare - America First Policy Institute","headline":"Put Americans First by Ending Global Freeloading | Issue Brief | Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQVGllWkZWTUhhdDl5WHR4ZU1nS1Jfd3R1QTN5dWFUQmUwR19FNkpnZkc0Wm0tUnI3UDJjMlBKdWdoSHg3aU9NVElXUXpMdlFlVGNFTjRwMkNTRS00SU1tVTd2S1MwNUNVejBEQ1ZmV1lWdllPdEs0d2hYSVRDeF8xMWxGaTNkQQ?oc=5","date":"2024-09-05","type":"pipeline","source":"Reason Foundation","summary":"How America subsidizes medicine across the world - Reason Foundation","headline":"How America subsidizes medicine across the world","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}